Amber Van Laar

4PUBLICATIONS
15CO-AUTHORS
Genetically modified animalsGene and molecular therapyAutonomic nervous systemPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 21, 2025
Intraputaminal Delivery of Adeno-Associated Virus Serotype 2-Glial Cell Line-Derived Neurotrophic Factor in Mild or Moderate Parkinson's Disease.

Amber D Van Laar, Chadwick W Christine, Nicolás Phielipp

|Aug 08, 2022
Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial.

Chadwick W Christine, R Mark Richardson, Amber Van Laar

|Oct 15, 2021
Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial.

Chadwick W Christine, R Mark Richardson, Amber D Van Laar

|Jul 27, 2018
LRRK2 activation in idiopathic Parkinson's disease.

Roberto Di Maio, Eric K Hoffman, Emily M Rocha

Pageof 1

Frequent Collaborators

1 joint publications

R Mark Richardson

1 joint publications

Chadwick W Christine

1 joint publications

Nicolás Phielipp

1 joint publications

Aristide Merola